Publication | Open Access
Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin
67
Citations
59
References
2018
Year
MedicineMechanism Of ActionExperimental PharmacologyPharmacotherapyTrek-1 Potassium ChannelDepressive-like EffectsPharmacologyCell BiologyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1